Recombinant factor VIIa for refractory bleeding following orthotopic heart transplantation

Annals of Pharmacotherapy

Volumn 38, Issue 10, 2004, Pages 1639-1642

  Flynn, Jeremy D ^a   Pajoumand, Mehrnaz ^a   Camp Jr , Phillip C ^b   Jahania, M Salik ^b   Ramaiah, Chand ^b   Akers, Wendell S ^c  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c University of Kentucky   (United States)

Author keywords

Bleeding; Factor VIIa; Heart transplantation; Ventricular assist device

Indexed keywords

FRESH FROZEN PLASMA; HEMOSTATIC AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTICLE; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; CARDIOMYOPATHY; CASE REPORT; CLINICAL RESEARCH; DISEASE ASSOCIATION; ERYTHROCYTE TRANSFUSION; HEART ASSIST DEVICE; HEART LEFT VENTRICLE; HEART SURGERY; HEART TRANSPLANTATION; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; IDIOPATHIC DISEASE; INOTROPISM; INTENSIVE CARE; INTUBATION; MALE; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

BLOOD COAGULATION DISORDERS; BLOOD TRANSFUSION; FACTOR VII; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; SALVAGE THERAPY; TIME FACTORS;

EID: 4644330060     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E123     Document Type: Article

References (12)

1. Von Heymann C, Hotz H, Konertz W, Kox WJ, Spies C. Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery. J Cardiothorac Vase Anesth 2002; 16:615-6.
2. Naik VN, Mazer CD, Latter DA, Teitel JM, Hare GMT. Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass. Can J Anaesth 2003;50:599-602.
3. Koh MBC, Hunt BJ. The management of perioperative bleeding. Blood Rev 2003;17:179-85.
4. Park P, Fewel ME, Carton HJ, Thompson BG, Hoff JT. Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients. Neurosurgery 2003;53:34-9.
5. Dutton RP, Hess JR, Scalea TM. Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients. J Clin Anesth 2003;15:184-8.
6. Potapov EV, Pasic M, Bauer M, Hetzer R. Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device. Ann Thorac Surg 2002;74:2182-3.
7. Hendriks HGD, Van der Maaten JMAA, De Wolf J, Waterbolk TW, Slooff MJH, Van der Meer J. An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg 2001;93:287-9.
8. Zietkiewicz M, Garlicki M, Domagala J, Wierzbicki K, Drwila R, Pfitzner R, et al. Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with a left ventricular assist device. J Thorac Cardiovasc Surg 2002;123:384-5.
9. Al Douri M, Shafi T, Al Khudairi D, Al Bokhari E, Black L, Akinwale N, et al. Effect of the administration of recombinant factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery. Blood Coagul Fibrinolysis 2000;11(suppl 1):S121-7.
10. Hedner U, Erhardtsen E. Potential role for rFVIIa in transfusion medicine. Transfusion 2002;42:114-24.
11. Product information. NovoSeven (coagulation factor VIIa, recombinant). Princeton, NJ: Novo Nordisk, February 2003.
12. Dietrich W, Spannagl M. Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery. Anesth Analg 2002;94:1365-76.